Core Viewpoint - The company, Zhejiang Anglikang Pharmaceutical Co., Ltd., has announced its 2025 semi-annual profit distribution plan, which includes a cash dividend of 1.00 RMB per 10 shares for shareholders, excluding shares held in the company's repurchase account [2][6]. Group 1: Profit Distribution Plan - The total number of shares eligible for the profit distribution is 196,108,486, calculated by deducting 5,619,700 shares held in the repurchase account from the total share capital of 201,728,186 [2][6]. - The total cash dividend amount to be distributed is 19,610,848.60 RMB, calculated as 196,108,486 shares multiplied by 0.10 RMB per share [2][12]. - The cash dividend will be distributed on a basis of 1.00 RMB per 10 shares, with specific tax implications for different categories of shareholders [6][7]. Group 2: Shareholder Meeting and Approval - The profit distribution plan was approved at the company's first extraordinary general meeting held on October 16, 2025 [3][4]. - The distribution plan is consistent with the principles established during the shareholder meeting, ensuring that any changes in total share capital due to repurchases or other factors will be adjusted accordingly [4][5]. Group 3: Key Dates - The record date for the profit distribution is set for November 21, 2025, and the ex-dividend date is November 24, 2025 [8][9]. Group 4: Distribution Method - Cash dividends for A-share shareholders will be directly credited to their accounts through their respective securities companies on the ex-dividend date [10]. - The company will bear all legal responsibilities for any discrepancies in dividend distribution due to changes in shareholder accounts during the application period [11].
浙江昂利康制药股份有限公司 2025年半年度权益分派实施公告